229 related articles for article (PubMed ID: 21156341)
21. Menopause and the risk of coronary heart disease in women.
Colditz GA; Willett WC; Stampfer MJ; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1987 Apr; 316(18):1105-10. PubMed ID: 3574358
[TBL] [Abstract][Full Text] [Related]
22. Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review.
Fournier A
Menopause Int; 2010 Mar; 16(1):23-32. PubMed ID: 20424283
[TBL] [Abstract][Full Text] [Related]
23. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
24. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
Ettinger B
Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
[TBL] [Abstract][Full Text] [Related]
26. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
Dubey RK; Imthurn B; Barton M; Jackson EK
Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
[TBL] [Abstract][Full Text] [Related]
27. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
Canonico M; Scarabin PY
Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
[No Abstract] [Full Text] [Related]
28. Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation.
Lobo RA; Clarkson TB
Menopause; 2011 Feb; 18(2):237-40. PubMed ID: 21341399
[TBL] [Abstract][Full Text] [Related]
29. Hormone therapy. An update on risks and benefits.
Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
[No Abstract] [Full Text] [Related]
30. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy and the menopause. Australian Menopause Society.
MacLennan AH
Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
[No Abstract] [Full Text] [Related]
32. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].
Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684
[No Abstract] [Full Text] [Related]
33. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
34. The menopause: benefits and risks of hormone replacement therapy.
Gambrell RD
Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
[No Abstract] [Full Text] [Related]
35. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
36. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
37. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
Clarkson TB; Karas RH
Menopause; 2007; 14(6):963-7. PubMed ID: 17909452
[No Abstract] [Full Text] [Related]
38. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Shulman LP
J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
[No Abstract] [Full Text] [Related]
39. [Estrogens and progestins in hormone replacement therapy in menopause].
La Vecchia C
Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
[TBL] [Abstract][Full Text] [Related]
40. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
N Engl J Med; 1974 Jan; 290(1):15-9. PubMed ID: 4357161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
